Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
1.360
-0.040 (-2.86%)
Oct 29, 2024, 4:00 PM EDT - Market closed
Century Therapeutics Revenue
Century Therapeutics had revenue of $771.00K in the quarter ending June 30, 2024, with 678.79% growth. This brings the company's revenue in the last twelve months to $2.04M, down -55.28% year-over-year. In the year 2023, Century Therapeutics had annual revenue of $2.24M, down -57.01%.
Revenue (ttm)
$2.04M
Revenue Growth
-55.28%
P/S Ratio
43.95
Revenue / Employee
$12,370
Employees
165
Market Cap
115.21M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.24M | -2.96M | -57.01% |
Dec 31, 2022 | 5.20M | - | - |
Dec 31, 2021 | - | - | - |
Dec 31, 2020 | - | - | - |
Dec 31, 2019 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Quipt Home Medical | 244.23M |
Rockwell Medical | 94.37M |
OptiNose | 75.06M |
908 Devices | 52.69M |
KORU Medical Systems | 30.82M |
TriSalus Life Sciences | 24.74M |
Myomo | 21.11M |
Seer, Inc. | 14.74M |
IPSC News
- 4 weeks ago - Century Therapeutics Strengthens Leadership Team with Appointments of Chief Financial Officer and Chief Scientific Officer - GlobeNewsWire
- 2 months ago - Century Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates - GlobeNewsWire
- 4 months ago - Century Therapeutics: Cell Therapy Biotech With Expanded Potential Of CNTY-101 - Seeking Alpha
- 5 months ago - Century Therapeutics Presents Interim Results from Phase 1 ELiPSE-1 Study at ASCO 2024 Annual Meeting - GlobeNewsWire
- 6 months ago - Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates - GlobeNewsWire
- 6 months ago - Century Therapeutics to Present at Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit - GlobeNewsWire
- 7 months ago - Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics - GlobeNewsWire
- 7 months ago - Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting - GlobeNewsWire